Baycan et al: hdl-c and long-term mortality in patients with covid-19 pneumonia

HIGHLIGHTS

• who: Şeyma BAYCAN from the of Cardiology, ProfDrYalcin City Hospital, Turkey have published the Article: Baycan et al: HDL-C and long-term mortality in patients with COVID-19 pneumonia, in the Journal: (JOURNAL) of 31/Dec/2020
• what: The authors aimed to show the effect of HDL-C in patients with COVID-19 on their long-term prognosis. The authors report that, among the lipoproteins known to have important roles in viral infections and the immune system, HDL-C predicts long-term mortality in COVID-19.
• how: Grading of computerized tomography evidence . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.